Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Bottoni, F. & Tilanus, M. The natural history of juxtafoveal and subfoveal choroidal neovascularization in high myopia. Int Ophthalmol 24, 249–255 (2001).
2. Wang, J. K., Huang, T. L., Su, P. Y. & Chang, P. Y. Approved pharmacotherapy for myopic choroidal neovascularization: a review of randomized controlled trials in ranibizumab and aflibercept. Eye Sci 30, 198–200 (2015).
3. Yamamoto, Y. et al. Associations of inflammatory cytokines with choroidal neovascularization in highly myopic eyes. Retina 35, 344–350 (2015).
4. Ruiz-Moreno, J. M. et al. Myopic choroidal neovascularization. Ophthalmology 118, 2521–2523 (2011).
5. Parodi, M. B., Iacono, P., Papayannis, A., Sheth, S. & Bandello, F. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia. Arch Ophthalmol 128, 437–442 (2010).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献